Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Chilena Infectol ; 26(5): 435-9, 2009 Oct.
Article in Spanish | MEDLINE | ID: mdl-19915753

ABSTRACT

Most surveillance studies have included invasive candidiasis from hospitalized patients. However, no national study has evaluated the species distribution and susceptibility to fluconazole of Candida species isolated from hospitalized and ambulatory patients. A total of 166 strains were collected consecutively during a 6 month period. Strains were isolated from vaginal fluid (73.5%), urine (7.8%), lower respiratory tract samples (7.8%), blood cultures (4.2%), sterile fluids (2.4%) and wounds (1.8%). Most of the isolates were obtained from ambulatory patients (71.1%). The species found were Candida albicans (78.9%), C. glabrata (8.4%), C. tropicalis (6.0%), C. famata (1.8%), C. krusei (1.8%), C. parapsilosis (1.8%) and C. sake (1.2%). Fluconazole susceptibility was: 92.3%o for C. albicans, 85.7 % for C. glabrata (most strains being dose-dependent susceptible), 100%) for C. parapsilosis and 80%) for C. tropicalis. Only susceptible strains were isolated from hospitalized children, whereas more resistant strains were isolated from ambulatory adults, mainly from vaginal fluid. In order to identify probable reservoirs of less susceptible strains such as C. glabrata, it would be necessary to include ambulatory isolates in future surveillance studies.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Fluconazole/pharmacology , Adolescent , Adult , Candida/classification , Candida/isolation & purification , Child , Female , Humans , Infant , Male , Microbial Sensitivity Tests
2.
Rev Chilena Infectol ; 26(6): 515-9, 2009 Dec.
Article in Spanish | MEDLINE | ID: mdl-20098785

ABSTRACT

UNLABELLED: Chitosan is a D-glucosamine polysaccharide derived from chitin that displays an antimicrobial activity against bacteria and fungi. OBJECTIVE: to evaluate the antifungal effect of high molecular weight chitosan (HMWC) in clinical strains of Candida spp. METHODOLOGY: the susceptibility of forty strains of Candida spp. to HMWC was studied (16 C albicans, 11 C glabrata, 5 C. tropicalis, 5 C krusei, 2 C parapsilosis and 2 C. famata) by broth microdilution at pH 7.0 and pH 4.0. RESULTS: of 40 strains, only 2 were inhibited at pH 7.0 and corresponded to ATCC control strains (C. krusei 6258 and C parapsilosis 22019). On the other hand, 37/40 strains (92.5%) were inhibited by concentrations lower than 1.25 mg/mL of HMWC at pH 4.0. CONCLUSION: these results show that HMWC, presents activity against clinical Candida spp. strains, including C glabrata, and that this activity is present at acid pH (4.0). This compound could potentially be used in vulvovaginal candidiasis since it occurs at pH 4.0-4.5.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Chitosan/pharmacology , Antifungal Agents/chemistry , Candida/classification , Chitosan/chemistry , Colony Count, Microbial , Microbial Sensitivity Tests/methods , Molecular Weight
SELECTION OF CITATIONS
SEARCH DETAIL
...